e-learning
resources
Vienna 2012
Monday, 03.09.2012
Trials in asthma: asthma exacerbations and severe asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Usability evaluation of NEXThaler® versus Diskus® and Turbuhaler®
P.G. Linnane, T. Voshaar, M. Spinola, A. Campanini, D. Lock, M. Scuri, B. Ronca, A.S. Melani (Parma, Siena, Italy; Moers, Germany; London, United Kingdom)
Source:
Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma
Session:
Trials in asthma: asthma exacerbations and severe asthma
Session type:
Poster Discussion
Number:
1797
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P.G. Linnane, T. Voshaar, M. Spinola, A. Campanini, D. Lock, M. Scuri, B. Ronca, A.S. Melani (Parma, Siena, Italy; Moers, Germany; London, United Kingdom). Usability evaluation of NEXThaler® versus Diskus® and Turbuhaler®. Eur Respir J 2012; 40: Suppl. 56, 1797
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Patient assessments of ease of use of Genuair® versus Aerolizer® and HandiHaler®
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011
Evaluation of pulmonary diffusion: TL
CO
or K
CO
?
Source: Annual Congress 2010 - Advances in lung function I
Year: 2010
The results of drug resistance survey of MDR-strains on second line drugs obtains in national reference laboratory – " M.Nasta " Institute – Bucharest
Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2011
Documentation & accuracy of smoking status – An educational need?
Source: Annual Congress 2011 - Smoking cessation science and smoking-related disorders
Year: 2011
Optimization of inhalation treatment – Evaluation of influence of PNEUMOlogic® and Optimiser® spacers on aerosol particle distribution from pMDI-EB
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I
Year: 2011
Nutritional risk screening 2002 – Application in pneumology
Source: Annual Congress 2012 - New insights in the clinical management of lung diseases
Year: 2012
Quality of life in asthmatic children "
a comparative study of patients‘ and parents‘ perceptions
"
Source: Annual Congress 2011 - Coping and lifestyle in childhood asthma
Year: 2011
Smoking assessment & treatment in hospital: Are we providing ‘right care‘ and/or missing cannabis-smoking?
Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment
Year: 2011
Comparison between SCOT-15® and Perfadex® as lung preservation solutions
Source: Annual Congress 2011 - Immunobiology in the transplanted lung: experimental and clinical evaluations
Year: 2011
CREWS – A preliminary evaluation
Source: Annual Congress 2010 - Palliative care, oxygen and community care for chronic lung disease
Year: 2010
Airway resistances: R
aw
, sR
aw
, sR
eff
– Which is the best determinant of airway function?
Source: Annual Congress 2010 - Lung function from infancy to adulthood
Year: 2010
Transcutaneous measurement of pCO
2
(p
tc
CO
2
): Time delay from change in alveolar pCO
2
to first response in p
tc
CO
2
Source: Annual Congress 2011 - Sleep and weight: heavy under pressure
Year: 2011
Patients‘ knowledge about inhalation therapy in pulmology – One year after intervention
Source: Annual Congress 2011 - Medical education
Year: 2011
CREWS – A validation pilot
Source: Annual Congress 2012 - The latest insights in integrated care
Year: 2012
Alterations in
ORMDL
expression in experimental esthma
Source: Annual Congress 2012 - Mechanisms and risk of childhood asthma and allergy
Year: 2012
Over-reading spirometry – Man or machine?
Source: Annual Congress 2011 - Quality control in lung function and exercise-related issues
Year: 2011
The ‘Sleep-Disordered Breathing in Patients with Neuromuscular Disease‘ questionnaire (SiNQ-5) – Clinical usefulness in a tertiary referral centre
Source: Annual Congress 2012 - Technology, screening and questionnaires in OSA
Year: 2012
LungPoint® – A new approach to peripheral lung lesions
Source: Annual Congress 2010 - Tissue is mostly the issue: diagnostic and therapeutic bronchoscopy
Year: 2010
EGFR
,
HER2
and
KRAS
mutational status according to adenocarcinoma patterns/sub-types
Source: Annual Congress 2011 - Genetics of airway diseases and treatment
Year: 2011
Clinical decision making in alpha
1
antitrypsin deficiency emphysema – Methodologies to determine individual rates of FEV
1
decline
Source: Annual Congress 2010 - Novel biomarkers and old parameters in approaching pulmonary diseases
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept